AbSci
Company Profile
Industry:Biotechnology
Site:abscibio.com
Description:AbSci has developed a proprietary bioengineered E. coli expression platform that allows for easily optimizable and scalable soluble production of complex proteins, including monoclonal antibodies. This breakthrough technology eliminates inclusion body formation, and aims to replace mammalian systems as the primary platform for expression of these valuable proteins.
Founded:2011
Company size:1-10 employees
Former Employees
Position at AbSci | Next job position | |
---|---|---|
Robin Cape | Senior Project ManagerSince Jan 2010 |
RLCape ConsultingOwner and consultant Since Jan 2010 |